Solventum Corp reported $437M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Align Technology USD 229.14M 31.74M Mar/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Cencora USD 1.41B 207.69M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Solventum Corp USD 437M 0 Mar/2026
West Pharmaceutical Services USD 243.6M 17.4M Jun/2026
Zimmer Biomet Holdings USD 640.1M 118.9M Mar/2026